We are Sorry, This Page doesn't Exist
Bristol-Myers Posts Data on Empliciti, China Approves Opdivo
Bristol-Myers (BMY) announces positive results on oncology drug Empliciti. The company's blockbuster drug, Opdivo, was also approved in China for lung cancer. Br.....»»
Bristol-Myers: FDA approves Opdivo for patients with metastatic SCLC
See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»
Bristol-Myers receives positive CHMP opinion recommending Opdivo plus Yervoy
See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»
Bristol-Myers announces EMA"s CHMP recommends approval of Opdivo
See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»
Bristol-Myers announces approval of Opdivo plus Cabometyx for carcinoma
See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»
Bristol-Myers to withdraw Opdivo indication in SCLC
See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»
Bristol-Myers to withdraw Opdivo indication in SCLC
See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»
Bristol-Myers reports FDA approval for fifth indication for Opdivo + Yervoy
See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»
Bristol-Myers: FDA accepts sBLA for Opdivo plus Yervoy
See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»
Bristol-Myers withdraws European application of Opdivo+Yervoy in NSCLC
See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»
Bristol-Myers announces data from multiple liso-cel studies at ASH meeting
See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»
Bristol-Myers says FDA accepts Opdivo/Yervoy combo for priority review in HCC
See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»
Bristol-Myers announces efficacy data analysis from Phase 3 CheckMate -238 trial
See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»
Bristol-Myers to Sell Otezla for Celgene Merger, Shares Down
Bristol-Myers (BMY) declines as it announces to sell Otezla to settle FTC concerns, while Opdivo fails in liver .....»»
Bristol-Myers reports updated efficacy data from Phase 2 Empliciti combo trial
See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»
Bristol-Myers" Opdivo+Yervoy HCC study yields 31% ORR
See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»
Bristol-Myers Reports Positive Data in NSCLC Trial on Opdivo
Bristol-Myers Squibb Company (BMY) announced positive results from the phase III trial, CheckMate -0.....»»
Bristol-Myers: Opdivo plus Yervoy showed benefit for coprimary endpoint in study
See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»
Bristol-Myers announces EMA validation of type 2 application for Opdivo
See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»
Bristol-Myers announces updated results from CheckMate -238 trial
See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»